Trump Negotiates Landmark Deal with Lilly, Novo Nordisk to Offer Obesity Drugs for $149
The Trump administration is close to a major deal with drugmakers Eli Lilly and Novo Nordisk. The focus is on cutting the cost of powerful weight-loss drugs. These drugs include Zepbound and Wegovy. The goal is to make the treatments much more affordable. Sources familiar with the talks say the lowest doses could sell for…
